Effect of ivabradine on cardiac arrhythmias: Antiarrhythmic or proarrhythmic?
- 1 July 2021
- journal article
- review article
- Published by Elsevier in Heart Rhythm
- Vol. 18 (7) , 1230-1238
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Selective heart rate reduction with ivabradine slows ischaemia-induced electrophysiological changes and reduces ischaemia–reperfusion-induced ventricular arrhythmiasJournal of Molecular and Cellular Cardiology, 2013
- Increased Expression of HCN Channels in the Ventricular Myocardium Contributes to Enhanced Arrhythmicity in Mouse Failing HeartsJournal of the American Heart Association, 2013
- Effects of Ivabradine on the Pulmonary Vein Electrical Activity and Modulation of Pacemaker Currents and Calcium HomeostasisJournal of Cardiovascular Electrophysiology, 2011
- Long‐term treatment with ivabradine in post‐myocardial infarcted rats counteracts f‐channel overexpressionBritish Journal of Pharmacology, 2011
- Safety of Ivabradine in Patients With Coronary Artery Disease and Left Ventricular Systolic Dysfunction (from the BEAUTIFUL Holter Substudy)The American Journal of Cardiology, 2011
- Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled studyThe Lancet, 2010
- Dynamic changes in HCN2, HCN4, KCNE1, and KCNE2 expression in ventricular cells from acute myocardial infarction rat heartsBiochemical and Biophysical Research Communications, 2010
- Chronic heart rate reduction with ivabradine improves systolic function of the reperfused heart through a dual mechanism involving a direct mechanical effect and a long-term increase in FKBP12/12.6 expressionEuropean Heart Journal, 2009
- Transcription profiling of HCN-channel isotypes throughout mouse cardiac developmentBasic Research in Cardiology, 2009
- Molecular basis of funny current (If) in normal and failing human heartJournal of Molecular and Cellular Cardiology, 2008